ULTRALIFE CORP(ULBI)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,917 of 2,879 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
ULBI Stock Analysis & AI Quality Score
AI stock analysis and institutional research for ULTRALIFE CORP (ULBI), a Technology sector company. 13F Pro's AI-powered ranking engine scores ULBI at 40.8/100 on a 32-signal composite quality model, placing it at rank #1,917 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include earnings quality (2.2) and institutional flow (18.4), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), ULTRALIFE CORP reports quarterly revenue of $47.4M, net income of $-451.0K, an operating margin of -0.4%. Top institutional holders of ULBI by reported 13-F value include Visionary Wealth Advisors, DIMENSIONAL FUND ADVISORS, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. ULBI trades on the Nasdaq exchange and files with the SEC under CIK 875657. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ULBI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ULTRALIFE CORP directly from SEC EDGAR. ULTRALIFE CORP's 13F Pro composite quality score has ranged between 25 and 60 since 2021, currently 40.8 — a declining long-term trajectory across 30 quarterly and live scoring snapshots.
Revenue
Q1 2026
$47.4M
Net Income
Q1 2026
$-451.0K
Free Cash Flow
Q1 2026
$1.5M
Operating Margin
Q1 2026
-0.4%
ROIC
Q1 2026
-0.1%
D/E Ratio
Q1 2026
0.37
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+16.2% YoYNet Income
-193.4% YoYOperating Income
-159.2% YoYEPS (Diluted)
-192.1% YoYTotal Assets
-1.6% YoYTotal Debt
-14.0% YoYOp. Cash Flow
-33.9% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $191.2M +16.2% | $164.5M +3.7% | $158.6M +20.3% | $131.8M +34.2% | $98.3M -8.8% | $107.7M |
| Net Income | $-5.9M -193.4% | $6.3M -12.3% | $7.2M +6147.9% | $-119.0K +49.1% | $-234.0K -104.5% | $5.2M |
| Operating Income | $-5.9M -159.2% | $10.0M +5.2% | $9.5M +7245.0% | $129.0K +268.6% | $35.0K -99.4% | $5.7M |
| EPS (Diluted) | $-35.00 -192.1% | $38.00 +8536.4% | $0.44 +780.0% | $0.05 +0.0% | $0.05 -84.8% | $0.33 |
| Total Assets | $216.9M -1.6% | $220.5M +23.7% | $178.3M +5.8% | $168.4M +5.6% | $159.5M +15.9% | $137.7M |
| Total Debt | $49.7M -14.0% | $57.8M +108.1% | $27.7M +18.1% | $23.5M +12.7% | $20.9M +1432.5% | $1.4M |
| Operating Cash Flow | $11.0M -33.9% | $16.6M +762.4% | $1.9M +252.7% | $-1.3M -129.2% | $4.3M -80.1% | $21.7M |
AI Insight: ULBI Financial Trends
Ultralife's operating income swung from +$4M in Q2 2024 to -$11M in Q4 2025, eroding equity and signaling a sharp profitability deterioration.
• Operating income collapsed from $4M in Q2 2024 to -$11M in Q4 2025, marking a stark reversal over six quarters.
• Total debt surged from $8M in Q3 2024 to $58M in Q4 2024, remaining elevated at $48M in Q1 2026.
• Equity eroded from $138M in Q2 2025 to $130M in Q1 2026, reflecting cumulative net losses.
• Operating cash flow has been near zero for three consecutive quarters (Q3 2025–Q1 2026), ranging from $0M to $2M.
⚠ Q4 2025 net loss of -$7M and op loss of -$11M are outlier magnitudes — monitor whether Q1 2026 breakeven holds.
⚠ Debt remains ~$50M versus near-zero pre-acquisition levels; debt reduction pace is critical to watch.
⚠ Revenue has held $43M–$51M across all eight quarters — stability here is the one constructive data point.
AI Insight: ULBI Ratio Trends
A severe Q4 2025 loss dragged TTM profitability deeply negative, erasing the gains seen through mid-2025.
• Operating margin collapsed to -21.9% in Q4 2025 from +4.7% in Q2 2025, pulling TTM OpMargin to -5.1%.
• ROIC swung from a peak of 10.8% in Q2 2024 to -23.6% in Q4 2025, signaling capital destruction.
• Q1 2026 OpMargin partially recovered to -0.4% from -21.9% in Q4 2025, suggesting the Q4 hit may be partly one-off.
• D/E ratio rose sharply from 0.06 in Q3 2024 to 0.43 in Q4 2024 and remains elevated at 0.37 in Q1 2026.
⚠ Q4 2025's -21.9% OpMargin looks like a one-off; confirm whether Q1 2026's near-breakeven reflects genuine recovery.
⚠ D/E jumped from near-zero (0.06) to ~0.38 range — monitor whether leverage stabilizes or continues climbing.
⚠ ROE turned deeply negative at -22.8% in Q4 2025; sustained losses risk further balance sheet erosion.
Get alerted when ULBI's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for ULTRALIFE CORP including:
Top Institutional Holders of ULBI
Visionary Wealth Advisors
$7.2M1,106,154 shDIMENSIONAL FUND ADVISORS LP
$6.5M994,846 shVANGUARD CAPITAL MANAGEMENT LLC
$3.0M457,837 shTruffle Hound Capital, LLC
$1.6M250,000 shRBF Capital, LLC
$1.4M218,714 shRENAISSANCE TECHNOLOGIES LLC
$1.3M198,090 shConnor, Clark & Lunn Investment Management Ltd.
$1.0M155,021 shBlackRock, Inc.
$953.7K146,273 shRAYMOND JAMES FINANCIAL INC
$908.5K139,333 shGEODE CAPITAL MANAGEMENT, LLC
$830.8K127,339 sh
| Fund | Value | Shares |
|---|---|---|
| Visionary Wealth Advisors | $7.2M | 1,106,154 |
| DIMENSIONAL FUND ADVISORS LP | $6.5M | 994,846 |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.0M | 457,837 |
| Truffle Hound Capital, LLC | $1.6M | 250,000 |
| RBF Capital, LLC | $1.4M | 218,714 |
| RENAISSANCE TECHNOLOGIES LLC | $1.3M | 198,090 |
| Connor, Clark & Lunn Investment Management Ltd. | $1.0M | 155,021 |
| BlackRock, Inc. | $953.7K | 146,273 |
| RAYMOND JAMES FINANCIAL INC | $908.5K | 139,333 |
| GEODE CAPITAL MANAGEMENT, LLC | $830.8K | 127,339 |
More Technology Companies
View all Technology →Put ULBI on your watchlist
Track score changes the day ULTRALIFE CORP files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ULBI a good stock to buy?
13F Pro's AI-powered analysis of ULTRALIFE CORP (ULBI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ULBI are available on the ULBI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own ULBI?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ULBI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of ULTRALIFE CORP's investment landscape.